Skip to content
Brand AI

Labcorp

Recent events

Recent events tied to this brand in public sources.

Back to profile8 entries

  1. 2026

    Labcorp agrees to acquire select BioReference Health assets

    Labcorp agreed to acquire select laboratory testing and operational assets from BioReference Health for $722 million in cash at closing, with a potential earnout of up to $150 million tied to 4Kscore Test revenue. The transaction remains subject to regulatory approvals and customary closing conditions.

    Source

  2. 2026

    Labcorp reaches $2.3 million settlement over data breach affecting 451,558 Marylanders

    Labcorp reached a $2.3 million settlement connected to a data breach that the report says impacted 451,558 Maryland residents.

    Source

  3. 2022

    Labcorp announces Labcorp OnDemand launch

    Labcorp announced the launch of Labcorp OnDemand, a platform where individuals can purchase tests online, collect samples at home, or schedule appointments at patient service centers.

    Source

  4. 2021

    PetDx completes Series B financing

    PetDx announced completion of its Series B financing, raising more than $62 million in new capital. The financing was led by Longview Asset Management, with several other investors participating.

    Source

  5. 2021

    Biospectal closes $4.3 million seed funding round

    Biospectal announced the closing of a $4.3 million (€3.7 million) seed funding round led by digital health investor SeedLink, with additional funding from LabCorp, Athensmed and other European and US investors.

    Source

  6. 2020

    LabCorp withdraws 2020 financial guidance

    LabCorp said it was withdrawing its 2020 financial guidance, citing uncertainty regarding the COVID-19 pandemic.

    Source

  7. 2019

    LabCorp announces Jeffrey A. Davis board appointment

    LabCorp announced that it appointed Jeffrey A. Davis to its board of directors, effective December 1. Davis will also serve on the board’s audit committee and quality and compliance committee.

    Source

  8. 2015

    LabCorp completes acquisition of Covance

    Laboratory Corporation of America Holdings announced that it completed its acquisition of Covance. Covance common stock would cease trading and would no longer be listed on the NYSE.

    Source